f8k111413_chinajojodrug.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
Date of report (Date of earliest event reported):
|
November 14, 2013
|
|
CHINA JO-JO DRUGSTORES, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
|
001-34711
|
|
98-0557852
|
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
|
Room 507-513, 5th Floor, A Building, Meidu Plaza
Gongshu District, Hangzhou, Zhejiang Province
People’s Republic of China
|
|
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
Registrant’s telephone number, including area code
|
+86 (571) 88077078
|
|
N/A
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Item 2.02. Results of Operations and Financial Condition.
On November 14, 2013, the registrant announced its unaudited results of operations for the quarter ended September 30, 2013. A copy of the press release is annexed as Exhibit 99.1 hereto.
In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the registrant’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit
Number
|
|
Description
|
|
99.1
|
|
Press Release dated November 14, 2013
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| |
|
CHINA JO-JO DRUGSTORES, INC.
|
|
|
Date:
|
November 14, 2013
|
(Registrant)
|
|
| |
|
|
|
|
| |
|
By:
|
/s/ Ming Zhao
|
|
| |
|
|
Ming Zhao
|
|
| |
|
|
Chief Financial Officer
|
|